Index of Handouts

1: Ear, Nose and Throat At-A-Glance: Rhinoscopy, Radiology, Nitric Oxide, Rhinomanometry, Endoscopy
1-1JM: Junior Member | Hongfei Lou (China)
Symposium National Symposium 1: KAAACI/KAPARD Symposium - New Insights on Allergy and Asthma: Lessons From Epidemiologic Studies
1-1NAT: Asthma as an Entry Point of Non-Communicable Disease | Young Juhn (United States)
Workshop 1: Non-Allergic Rhinitis: Current Evidence and Unmet Needs
1-1WS: Classification of Non-Allergic Rhinitis | Stephen Tilles (United States)
Workshop 1: Non-Allergic Rhinitis: Current Evidence and Unmet Needs
1-2WS: Does Allergic Rhinitis Affect Communications Skills in Young Adults? | Cemal Cingi (Turkey)
New Horizons Session 1: Evidence in Allergen-Specific Immunotherapy
1-3NH: Immunotherapy for Japanese Cedar Pollinosis | Makoto Nagata (Japan)
Workshop 1: Non-Allergic Rhinitis: Current Evidence and Unmet Needs
1-3WS: Update on Pathomechanisms of Eosinophilic Rhinosinusitis | Yoshitaka Okamoto (Japan)
Symposium National Symposium 2: KAAACI/KAPARD Symposium - Asthma and Allergic Disease: From Environmental Trigger to Pharmacologic Treatment
2-1NAT: Impact of Particulate Matter on Allergic Diseases in Seoul | Young Yoo (South Korea)
Pediatric Track 2: Asthma in Children
2-1PED: Lessons from Cross-Sectional and Longitudinal Studies in Infants and Children | Luis Garcia-Marcos (Spain)
2: Lung Function and Bronchial Hyperreactivity Tests
2-2JM: Junior Member | Dongin Suh (South Korea)
Symposium National Symposium 2: KAAACI/KAPARD Symposium - Asthma and Allergic Disease: From Environmental Trigger to Pharmacologic Treatment
2-2NAT: The Impact of Inhaled Pollutants on Airway Inflammation | An-Soo Jang (South Korea)
Pediatric Track 2: Asthma in Children
2-2PED: Inhaled Steriods in Recurrent Wheezing Children | Elham Hossny (Egypt)
Symposium 2: Hot Topics in Asthma
2-2SY: Asthma Control and Treatment Issues | Christopher Kei Wai Lai (Hong Kong)
Company Sponsored Symposium 2: What We Know About Asthma Treatment
2-3CSS: Who can get the Most Benefit from Tiotropium in Asthma? | Yeonmok Oh (South Korea)
Sister Society Session 2: European Academy of Allergy and Clinical Immunology (EAACI) Symposium - Precision Medicine: From Molecular Signatures to Predicting Biomarkers
2-3SSS: Phenotypes and Endotypes of Allergic Rhinitis | Nikos Papadopoulos (United Kingdom)
New Horizons Session 3: Biologics in Severe Allergic Diseases
3-1NH: Anti-Cytokines in Severe Asthma | You Sook Cho (South Korea)
Workshop 3: Recent Update in Chronic Urticaria
3-1WS: Update in the Pathogenesis of Chronic Urticaria in Adults | Michihiro Hide (Japan)
Plenary Session 3: Atopic Dermatitis: From Barrier to Inflammation
3-2PS: Function and Dysfunction of Skin Barrier | Masayuki Amagai (Japan)
Workshop 3: Recent Update in Chronic Urticaria
3-2WS: Natural Course and Etiologic Factors of Chronic Urticaria in Children | Orathai Piboonpocanun (Thailand)
Company Sponsored Symposium 3: Molecular Allergy Diagnostics: Moving Towards Personalized Medicine in Allergy
3-3CSS: Clinical Reactivity vs. Tolerance: Examples from Egg and Milk Allergy | Katrina Allen (Australia)
Pediatric Track 3: Innovative Approaches in the Management of Asthma
3-3PED: The Novel Mechanism of Probiotics in Allergic Diseases | Jiu-Yao Wang (Taiwan)
Sister Society Session 3: American College of Allergy, Asthma and Immunology (ACAAI) Symposium - Challenges to the Practicing Allergist/Immunologist in the USA
3-3SSS: Choices in Immunotherapy: Sublingual Immunotherapy (SLIT) vs Subcutaneous (SCIT) Immunotherapy | Stanley Fineman (United States)
Symposium 3: Advances in the Management of Atopic Dermatitis: A Practical Approach
3-3SY: The Importance of Trigger Avoidance and Vitamin D Substitution | Ai-Young Lee (South Korea)
Company Sponsored Symposium 3: Molecular Allergy Diagnostics: Moving Towards Personalized Medicine in Allergy
3-4CSS: Food Allergy in Daily Practice: The Emerging Role of MA Diagnostics | Motohiro Ebisawa (Japan)
Pediatric Track 4: Why Don't Pharmacological Agents Work Well in Treatment of Asthma in Very Young Children?
4-1PED: The Pathology of the Airways in Very Young Children with Recurrent Wheeze | Elham Hossny (Egypt)
New Horizons Session 4: Innovative Technology in Allergen Immunotherapy
4-2NH: New Allergen Preparations in Sublingual Immunotherapy (SLIT) | Désirée Larenas-Linnemann (Mexico)
Pediatric Track 4: Why Don't Pharmacological Agents Work Well in Treatment of Asthma in Very Young Children?
4-2PED: Review of Efficacy of Current Pharmcological Agents in Very Young Children with Wheeze | Takao Fujisawa (Japan)
Plenary Session 4: Anaphylaxis through the Life Cycle
4-2PS: Does the Relative Importance of Anaphylaxis Triggers Differ from Infancy to Old Age? | Elham Hossny (Egypt)
Workshop 4: Allergies in the Tropics
4-2WS: Asthma in South Asia | Jessie De Bruyne (Malaysia)
Sister Society Session 5: Japanese Society of Allergology (JSA) Symposium - Innate Inflammation and Allergic Disease
5-1SSS: Pathogenic Th2 (Tpath2) Cells in Airway Inflammation | Toshinori Nakayama (Japan)
Symposium 5: Recent Advances in Understanding Asthma in the Elderly
5-1SY: Unraveling the Pathways to Asthma Development in the Elderly | Anahi Yañez (Argentina)
Workshop 5: Beyond IgE - Mediated Mechanisms in the Workplace
5-1WS: Baker's Asthma: A Model of Interacting between Innate and Th2 Immune Responses | Jonathan Bernstein (United States)
New Horizons Session 5: Endotypes of Chronic Rhinosinusitis: ICON Session
5-3NH: Developing Eosinophilic Chronic Rhinosinusitis | Chae-Seo Rhee (South Korea)
Sister Society Session 5: Japanese Society of Allergology (JSA) Symposium - Innate Inflammation and Allergic Disease
5-3SSS: Innate Lymphoid Cells in Allergic Inflammation | Shigeo Koyasu (Japan) ;
New Horizons Session 6: Critical Novel Molecules for Allergic Diseases
6-1NH: Role of Thymic Stromal Lymphopoietin (TSLP) in Allergic Responses | Atsushi Kato (United States)
Pediatric Track 6: Environment and Pediatric Allergy
6-1PED: Climate Change, Allergens and Pollinosis | Jae-Won Oh (South Korea)
Workshop 6: Patient Education and Adherence in Allergy and Atopic Dermatitis
6-1WS: Anaphylaxis in China | Jia Yin (China)
Sister Society Session 6: Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) Symposium - Important But Neglected Issues in Allergy
6-2SSS: Angioedema without Urticaria | Young Joo Cho (South Korea)
Symposium 6: Atopic Dermatitis: A Comprehensive Update
6-2SY: Management of Atopic Dermatitis and Emerging Therapies | Mark Boguniewicz (United States)
Workshop 6: Patient Education and Adherence in Allergy and Atopic Dermatitis
6-2WS: Education and Adherence in Atopic Dermatitis | Hye-Yung Yum (South Korea)
Symposium 6: Atopic Dermatitis: A Comprehensive Update
6-3SY: The Role of Environmental Allergens in the Pathogenesis of Atopic Dermatitis | Ichiro Katayama (Japan)
New Horizons Session 7: Food Immunotherapy: A Global Perspective
7-1NH: Immunotherapy in Food Allergy in Israel | Yitzhak Katz (Israel)
New Horizons Session 7: Food Immunotherapy: A Global Perspective
7-2NH: Immunotherapy in Food Allergy in Asia | Motohiro Ebisawa (Japan)
Workshop 7: Primary Immunodeficiency, Allergy and Inflammation
7-3WS: Profiles of Common Variables in Immunodeficiencies (CVID) | John Routes (United States)
Pediatric Track 8: What Have We Learned from Asthma Epidemiology Studies?
8-1PED: Phenotypes of Childhood Asthma | Myung Hyun Sohn (South Korea)
Symposium 8: Eosinophil Death Pathways
8-1SY: Eosinophil Death Receptors As Therapeutic Targets | Bruce Bochner (United States)
Workshop 8: Oral Immunotherapy for Pediatric Patients with Food Allergy in Asia
8-1WS: Safety and Feasiblity of Oral Immunotherapy for Food Allergy: Lessons from Asia | Sakura Sato (Japan)
Sister Society Session 8: Latin American Society of Allergy, Asthma and Immunology (SLaai) - Allergy to Drugs and New Tools and Outcome Measurement
8-2SSS: On-line Registry as a Tool for Describing Drug Hypersensitivities | Edgardo Jares (Argentina)
New Horizons Session 8: Personalized Medicine: The Way Forward in Allergy and Asthma
8-3NH: The Ethical Framing of Personalized Medicine | Heung Woo Park (South Korea)
Symposium 8: Eosinophil Death Pathways
8-3SY: Eosinophil Biology and Regulation of Eosinophil-Specific Genes | Il Yup Chung (South Korea)
New Horizons Session 9: Biomarkers, Biosimilars and Selection of Patients
9-1NH: The Use of Biomarkers in Asthma Clinical Research Trials | Takao Fujisawa (Japan)
Sister Society Session 9: WISC 2016 Symposium - Advances in the Evaluation and Management of Chronic Urticaria and Angioedema
9-1SSS: Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines | Jonathan Bernstein (United States)
Symposium 9: The Most Important Cause of Asthma in Children
9-1SY: A Combination of Genetic and Environmental Factors Is the Most Important Cause of Childhood Asthma | Mayumi Tamari (Japan)
Workshop 9: Neuro-Immune Interactions in Allergic Airways Diseases
9-1WS: Role of Sensory Neuronal Toll-like Receptors in Itch | Sung Joong Lee (South Korea)
New Horizons Session 9: Biomarkers, Biosimilars and Selection of Patients
9-2NH: Inner-City Asthma and Anti-IgE | Theresa Guilbert (United States)
Pediatric Track 9: Solutions for Allergy in School
9-2PED: Asthma in School | Takao Fujisawa (Japan)
Sister Society Session 9: WISC 2016 Symposium - Advances in the Evaluation and Management of Chronic Urticaria and Angioedema
9-3SSS: Patient Specific Characteristics in the Treatment of Chronic Urticaria: Does it Matter? | David Lang (United States)
Symposium 9: The Most Important Cause of Asthma in Children
9-3SY: Altered Immune Development Is the Most Important Cause of Childhood Asthma | James Gern (United States)
New Horizons Session 10: Update in Anaphylaxis: From Infancy to Old Age
10-3NH: Facing Issues of Management of Anaphylaxis | Margitta Worm (Germany)
New Horizons Session 11: The Microbiome and Its Impact on Allergic Disease
11-1NH: The Gut Microbiome on Health and Disease | Christina West (Sweden)
Workshop 11: Improving Adherence in Our Chronic Allergic Patients
11-3WS: What Can We Do to Improve Adherence for Our Patients? | Stanley Fineman (United States)
New Horizons Session 12: Drug Allergy
12-1NH: Protocols for Clinical Practice | Paige Wickner (United States)
Workshop 12: Best Evidence and Best Practice for Difficult Cases
12-1WS: Evidence-Based Diagnosis and Management of Severe Pruritus | David Lang (United States)
New Horizons Session 12: Drug Allergy
12-3NH: International Consensus on (ICON) Drug Allergy | Pascal Demoly (France)
New Horizons Session 13: Environmental Issues and Allergic Diseases
13-1NH: Urban Air Quality and Public Health | Jung-Won Park (South Korea)
Symposium 13: Development of Allergy: Lessons from the Birth Cohort Study
13-2SY: The Role of the Microbiome and Hygiene Hypothesis in the Development of Food Allergy | Katrina Allen (Australia)
Workshop 13: Airways Diseases in China
13-2WS: The Current Status of Allergic Diseases in Children in China | Jing Zhao (China)
Workshop 13: Airways Diseases in China
13-3WS: Asthma, Allergy and Environmental Exposure in Chinese Children | Jing Li (China)
Symposium 14: Innovative Approaches in Anaphylaxis
14-1SY: Use of Allergen Components: A New Era in Allergology | TBC
Symposium 14: Innovative Approaches in Anaphylaxis
14-2SY: Special Considerations on Anaphylaxis in Latin America | Edgardo Jares (Argentina)
Workshop 14: Exercise-Induced Bronchoconstriction (EIB) and Asthma
14-2WS: Indirect Bronchial Challenges to Diagnose Exercise-Induced Bronchoconstriction (EIB) | William Storms (United States)
Symposium 14: Innovative Approaches in Anaphylaxis
14-3SY: Immunologic Intervention of Drug-Induced Anaphylaxis | Masao Yamaguchi (Japan)
Workshop 14: Exercise-Induced Bronchoconstriction (EIB) and Asthma
14-3WS: Refractoriness during the Repeated Indirect Challenges | Young Yull Koh (South Korea)
Workshop 15: Cough Hypersensitivity Syndrome: A New Approach to Chronic Cough
15-1WS: Evolution of the "Cough Hypersensivity Syndrome" Concept | Alyn Morice (United Kingdom)
Workshop 15: Cough Hypersensitivity Syndrome: A New Approach to Chronic Cough
15-2WS: The Differences and Similarities Between Eosinophilic Bronchitis and Asthma | Kefang Lai (China)
Symposium 15: Eosinophils in Asthma and Allergy
15-3SY: Novel Targeted Therapies for Eosinophilic Disorders | Shigeharu Ueki (Japan)
Symposium 16: GLAD-P Symposium - Prevention of Allergy: Is it Possible?
16-2SY: Allergy Strategies Towards Prevention: The GLAD-P Project | Katrina Allen (Australia)
Workshop 16: New Methodology for Diagnosis of Allergic Disease
16-3WS: Novel Imaging Approach For Asthma | Akio Niimi (Japan)
Symposium 17: Mast Cell in Allergic Inflammation
17-1SY: Mast Cell Regulation of Allergic Inflammation | Mindy Tsai (United States)
Workshop 17: Small Airways (SAW) Working Group - Asthma Treatment Issues
17-2WS: New Bronchodilator for Asthma: LAMA and Ultra LABA | Stephen Peters (United States)
Symposium 17: Mast Cell in Allergic Inflammation
17-3SY: Mechanisms of Basophils and Mast Cell Function | Dean Metcalfe (United States)
Symposium 20: Respiratory Effectiveness Group Symposium: Harnessing the Real World to Address Unmet Needs in Allergy Care
20-1SY: Identifying Obstructive Lung Disease Using Routine Clinical Data: Methods and Real-Life Research Opportunities | Job Van Boven (Netherlands)
Symposium 21: Mechanisms in Anaphylaxis: Implications for Clinicians
21-1SY: How Can Drugs as Co-Factors Alter Anaphylaxis? | Margitta Worm (Germany)
Symposium 22: Update on the Mechanism of Asthma and Airway Inflammation
22-2SY: Basophil: A Key Player in Immunity and Inflammation | Hajime Karasuyama (Japan)
Symposium 22: Update on the Mechanism of Asthma and Airway Inflammation
22-3SY: Novel Targets for Airway Inflammation: Lessons from Distinct Functions of Subcellular Organelles | Yong Chul Lee (South Korea)